Claims assessment · Entity/finance claim
1.5°C-aligned” / “Paris-aligned
Typical treatment across five regimes. Every verdict below is tied to a stated legal hook.
Market comparison
How this claim is typically treated
Five major markets · one reviewed comparison
| Market | Typical treatment | Legal basis | What is required |
|---|---|---|---|
| European UnionEU | Restricted | Corporate Sustainability Reporting Directive (CSRD)Empowering Consumers Directive (EmpCo)Sustainable Finance Disclosure Regulation (SFDR)EU Taxonomy Regulation View legal reasoningSFDR/Taxonomy for funds; CSRD E1-1; UCPD future claims | Validated pathway; disclose metric scope (portfolio vs operations) |
| United KingdomUK | Restricted | DMCC Act 2024 — CMA green-claims enforcementFCA Sustainability Disclosure Requirements & investment labels (SDR) View legal reasoningCMA Code; FCA naming rules for funds | Credible transition plan; no implied official certification |
| United StatesUS | Conditional | View legal reasoningFTC s.5; SEC Names Rule for funds | Reasonable basis; 80% policy if ESG in name |
| CanadaCA | Restricted | View legal reasonings.74.01(1)(b.2) | Recognised methodology; scenario basis stated |
| AustraliaAU | Restricted | The cited source is recorded in the assessment. View legal reasoningACL; ASIC guidance for funds | Reasonable grounds; pathway assumptions |